venlafaxine hydrochloride has been researched along with Narcolepsy in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (46.67) | 29.6817 |
| 2010's | 8 (53.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bassetti, CL; Kallweit, U | 1 |
| Chen, BB; Jin, L; Liu, YH; Shi, L; Wang, XL; Zhang, Y | 1 |
| Greenberg, H; Wang, J | 1 |
| Chesson, AL; DelRosso, LM; Hoque, R; Munir, S | 1 |
| Møller, LR; Østergaard, JR | 1 |
| Baldovino, A; Delucchi, L; Martino, P; Pessina, P; Rodrigues, A | 1 |
| Aran, A; Einen, M; Lin, L; Mignot, E; Nishino, S; Plazzi, G | 1 |
| Bradshaw, DA; Crosby, MI; McLay, RN | 1 |
| Santamaria-Cano, J | 1 |
| Einen, M; Hecht, M; Kushida, CA; Lin, L; Mignot, E; Taheri, S; Umetsu, DT | 1 |
| Hindmarch, I; Rigney, U; Stanley, N; Trick, L | 1 |
| Gonzalez-Arriaza, HL; Krahn, LE | 1 |
| Berger, M; Feige, B; Nissen, C; Nofzinger, E; Riemann, D; Voderholzer, U | 1 |
| Barbiroli, B; Bernardi, F; Cicognani, A; Lin, L; Lodi, R; Mignot, E; Montagna, P; Parmeggiani, A; Plazzi, G; Posar, A; Scano, MC; Tonon, C | 1 |
| Albani, F; Montagna, P; Plazzi, G; Provini, F; Riva, R | 1 |
3 review(s) available for venlafaxine hydrochloride and Narcolepsy
| Article | Year |
|---|---|
Pharmacological management of narcolepsy with and without cataplexy.
Topics: Adult; Benzhydryl Compounds; Cataplexy; Drug Therapy, Combination; Humans; Modafinil; Narcolepsy; Neuropeptides; Off-Label Use; Orexins; Piperidines; Quality of Life; Sleep; Sodium Oxybate; Venlafaxine Hydrochloride; Wakefulness-Promoting Agents | 2017 |
A patient with intractable attacks of cataplexy.
Topics: Adult; Cataplexy; Combined Modality Therapy; Cyclohexanols; Diagnosis, Differential; Electroencephalography; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Narcolepsy; Neuropsychological Tests; Polysomnography; Psychotherapy; Risk Assessment; Severity of Illness Index; Venlafaxine Hydrochloride; Video Recording | 2013 |
[Diagnostic and therapeutic update in narcolepsy].
Topics: Adolescent; Adult; Age of Onset; Animals; Autoimmune Diseases; Benzhydryl Compounds; Cataplexy; Child; Clomipramine; Cyclohexanols; Delayed Diagnosis; Disease Models, Animal; Dogs; Genetic Predisposition to Disease; Histamine Agonists; HLA-DQ Antigens; HLA-DQ beta-Chains; Humans; Hypothalamus; Immunoglobulins, Intravenous; Intracellular Signaling Peptides and Proteins; Methylphenidate; Modafinil; Narcolepsy; Neuropeptides; Orexins; Polysomnography; Receptors, Antigen, T-Cell; Sodium Oxybate; Venlafaxine Hydrochloride | 2012 |
1 trial(s) available for venlafaxine hydrochloride and Narcolepsy
| Article | Year |
|---|---|
A double-blind, randomized, 26-week study comparing the cognitive and psychomotor effects and efficacy of 75 mg (37.5 mg b.i.d.) venlafaxine and 75 mg (25 mg mane, 50 mg nocte) dothiepin in elderly patients with moderate major depression being treated in
Topics: Aged; Cognition; Cyclohexanols; Depressive Disorder; Disorders of Excessive Somnolence; Dizziness; Dothiepin; Double-Blind Method; Drug Administration Schedule; Female; Flicker Fusion; Humans; Male; Narcolepsy; Nausea; Psychometrics; Psychomotor Performance; Time Factors; Venlafaxine Hydrochloride | 2004 |
11 other study(ies) available for venlafaxine hydrochloride and Narcolepsy
| Article | Year |
|---|---|
Antidepressants for the treatment of narcolepsy: A prospective study of 148 patients in northern China.
Topics: Adult; Antidepressive Agents; Female; Humans; Male; Middle Aged; Modafinil; Narcolepsy; Prospective Studies; Venlafaxine Hydrochloride | 2019 |
Status cataplecticus precipitated by abrupt withdrawal of venlafaxine.
Topics: Aged; Cataplexy; Cyclohexanols; Electroencephalography; Female; Humans; Hypertension; Narcolepsy; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride | 2013 |
Treatment with venlafaxine in six cases of children with narcolepsy and with cataplexy and hypnagogic hallucinations.
Topics: Cataplexy; Child; Cyclohexanols; Dose-Response Relationship, Drug; Female; Hallucinations; Humans; Male; Narcolepsy; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2009 |
Use of venlafaxine in the treatment of a canine narcolepsy-cataplexy case.
Topics: Animals; Cyclohexanols; Dog Diseases; Dogs; Female; Narcolepsy; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
Clinical and therapeutic aspects of childhood narcolepsy-cataplexy: a retrospective study of 51 children.
Topics: Adjuvants, Anesthesia; Adolescent; Age Distribution; Age of Onset; Antidepressive Agents, Second-Generation; Benzhydryl Compounds; Central Nervous System Stimulants; Child; Cyclohexanols; Drosophila Proteins; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Modafinil; Narcolepsy; Nerve Tissue Proteins; Nuclear Proteins; Overweight; Polysomnography; Puberty; Retrospective Studies; Sodium Oxybate; Streptococcal Infections; Surveys and Questionnaires; Transcription Factors; United States; Venlafaxine Hydrochloride; Weight Gain | 2010 |
Severe mania complicating treatment of narcolepsy with cataplexy.
Topics: Antidepressive Agents, Second-Generation; Benzhydryl Compounds; Bipolar Disorder; Central Nervous System Stimulants; Cyclohexanols; Drug Therapy, Combination; Humans; Male; Modafinil; Narcolepsy; Venlafaxine Hydrochloride; Young Adult | 2011 |
Report of a case of immunosuppression with prednisone in an 8-year-old boy with an acute onset of hypocretin-deficiency narcolepsy.
Topics: Acute Disease; Benzhydryl Compounds; Carrier Proteins; Central Nervous System Stimulants; Child; Cyclohexanols; HLA Antigens; Humans; Immunosuppressive Agents; Intracellular Signaling Peptides and Proteins; Male; Modafinil; Narcolepsy; Neuropeptides; Orexins; Polysomnography; Prednisone; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2003 |
Narcolepsy with cataplexy.
Topics: Adult; Cataplexy; Comorbidity; Cyclohexanols; Hallucinations; Humans; Male; Morpholines; Narcolepsy; Patient Education as Topic; Reboxetine; Selective Serotonin Reuptake Inhibitors; Sodium Oxybate; Venlafaxine Hydrochloride | 2004 |
Transient narcolepsy-cataplexy syndrome after discontinuation of the antidepressant venlafaxine.
Topics: Adult; Bipolar Disorder; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Dysthymic Disorder; Female; Humans; Male; Middle Aged; Narcolepsy; Polysomnography; Substance Withdrawal Syndrome; Treatment Failure; Venlafaxine Hydrochloride | 2005 |
Narcolepsy-cataplexy associated with precocious puberty.
Topics: Aspartic Acid; Benzhydryl Compounds; Cataplexy; Child; Creatine; Cyclohexanols; Disorders of Excessive Somnolence; Female; Hallucinations; Health Education; Humans; Hypothalamus; Intracellular Signaling Peptides and Proteins; Male; Modafinil; Narcolepsy; Neuropeptides; Night Terrors; Obesity; Orexins; Polysomnography; Puberty, Precocious; Television; Venlafaxine Hydrochloride | 2006 |
Treatment of narcolepsy with cataplexy.
Topics: Antidepressive Agents, Second-Generation; Cataplexy; Chemistry, Pharmaceutical; Cyclohexanols; Drug Administration Schedule; Humans; Narcolepsy; Venlafaxine Hydrochloride | 2007 |